137 related articles for article (PubMed ID: 37862131)
21. Population pharmacokinetics of vancomycin in critically ill patients receiving prolonged intermittent renal replacement therapy.
Economou CJP; Kielstein JT; Czock D; Xie J; Field J; Richards B; Tallott M; Visser A; Koenig C; Hafer C; Schmidt JJ; Lipman J; Roberts JA
Int J Antimicrob Agents; 2018 Aug; 52(2):151-157. PubMed ID: 29526606
[TBL] [Abstract][Full Text] [Related]
22. Daily vancomycin dose requirements as a continuous infusion in obese versus non-obese SICU patients.
Lin H; Yeh DD; Levine AR
Crit Care; 2016 Jul; 20(1):205. PubMed ID: 27363312
[TBL] [Abstract][Full Text] [Related]
23. Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting.
Broeker A; Nardecchia M; Klinker KP; Derendorf H; Day RO; Marriott DJ; Carland JE; Stocker SL; Wicha SG
Clin Microbiol Infect; 2019 Oct; 25(10):1286.e1-1286.e7. PubMed ID: 30872102
[TBL] [Abstract][Full Text] [Related]
24. Development of a Physiologically Based Pharmacokinetic Modelling Approach to Predict the Pharmacokinetics of Vancomycin in Critically Ill Septic Patients.
Radke C; Horn D; Lanckohr C; Ellger B; Meyer M; Eissing T; Hempel G
Clin Pharmacokinet; 2017 Jul; 56(7):759-779. PubMed ID: 28039606
[TBL] [Abstract][Full Text] [Related]
25. Cystatin C and/or creatinine-based estimated glomerular filtration rate for prediction of vancomycin clearance in long-stay critically ill patients with persistent inflammation, immunosuppression and catabolism syndrome (PICS): a population pharmacokinetics analysis.
Huang J; Wang X; Hao C; Yang W; Zhang W; Liu J; Qu H
Intern Emerg Med; 2021 Oct; 16(7):1883-1893. PubMed ID: 33728578
[TBL] [Abstract][Full Text] [Related]
26. Comparison of Vancomycin Clearance Between Augmented Renal Clearance and Normal Renal Function in Critically Ill Infants: A Population Pharmacokinetics Study.
Huang GM; Qiu Y; Liu TT; Lu JJ
J Clin Pharmacol; 2022 Jul; 62(7):863-872. PubMed ID: 35049078
[TBL] [Abstract][Full Text] [Related]
27. Population pharmacokinetic model of Vancomycin based on therapeutic drug monitoring data in critically ill septic patients.
Kovacevic T; Miljkovic B; Kovacevic P; Dragic S; Momcicevic D; Avram S; Jovanovic M; Vucicevic K
J Crit Care; 2020 Feb; 55():116-121. PubMed ID: 31715528
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive guidance for antibiotic dosing in obese adults: 2022 update.
Meng L; Mui E; Ha DR; Stave C; Deresinski SC; Holubar M
Pharmacotherapy; 2023 Mar; 43(3):226-246. PubMed ID: 36703246
[TBL] [Abstract][Full Text] [Related]
29. Concordance of Vancomycin Population-Predicted Pharmacokinetics with Patient-Specific Pharmacokinetics in Adult Hospitalized Patients: A Case Series.
Onor IO; Neuliep A; Tran KA; Lambert J; Gillard CJ; Brakta F; Ezebuenyi MC; St James K; Okogbaa JI; Beyl RA
Drugs R D; 2020 Jun; 20(2):83-93. PubMed ID: 32166646
[TBL] [Abstract][Full Text] [Related]
30. External Evaluation of Population Pharmacokinetic Models of Vancomycin in Large Cohorts of Intensive Care Unit Patients.
Guo T; van Hest RM; Roggeveen LF; Fleuren LM; Thoral PJ; Bosman RJ; van der Voort PHJ; Girbes ARJ; Mathot RAA; Elbers PWG
Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30833424
[TBL] [Abstract][Full Text] [Related]
31. Prospective evaluation of vancomycin pharmacokinetics in a heterogeneous critically ill population.
Turner RB; Kojiro K; Won R; Chang E; Chan D; Elbarbry F
Diagn Microbiol Infect Dis; 2018 Dec; 92(4):346-351. PubMed ID: 30025969
[TBL] [Abstract][Full Text] [Related]
32. Development of a new pharmacokinetic model for target-concentration controlled infusion of vancomycin in critically ill patients.
Bang JY; Kang HI; Lee HJ; Chong YP; Hong SK; Lee EK; Choi BM; Noh GJ
Clin Exp Pharmacol Physiol; 2022 Feb; 49(2):202-211. PubMed ID: 34596258
[TBL] [Abstract][Full Text] [Related]
33. Determination of optimal loading and maintenance doses for continuous infusion of vancomycin in critically ill patients: Population pharmacokinetic modelling and simulations for improved dosing schemes.
Vu DH; Nguyen DA; Delattre IK; Ho TT; Do HG; Pham HN; Dao XC; Tran NT; Nguyen GB; Van Bambeke F; Tulkens PM; Nguyen HA
Int J Antimicrob Agents; 2019 Dec; 54(6):702-708. PubMed ID: 31600554
[TBL] [Abstract][Full Text] [Related]
34. Predictive performance of reported population pharmacokinetic models of vancomycin in Chinese adult patients.
Deng C; Liu T; Wu K; Wang S; Li L; Lu H; Zhou T; Cheng D; Zhong X; Lu W
J Clin Pharm Ther; 2013 Dec; 38(6):480-9. PubMed ID: 24033587
[TBL] [Abstract][Full Text] [Related]
35. Updated antimicrobial dosing recommendations for obese patients.
Castro-Balado A; Varela-Rey I; Mejuto B; Mondelo-García C; Zarra-Ferro I; Rodríguez-Jato T; Fernández-Ferreiro A
Antimicrob Agents Chemother; 2024 May; 68(5):e0171923. PubMed ID: 38526051
[TBL] [Abstract][Full Text] [Related]
36. Vancomycin dosing in critically ill trauma patients: The VANCTIC Study.
Villanueva RD; Talledo O; Neely S; White B; Celii A; Cross A; Kennedy R
J Trauma Acute Care Surg; 2019 Nov; 87(5):1164-1171. PubMed ID: 31464871
[TBL] [Abstract][Full Text] [Related]
37. Population pharmacokinetic parameters of vancomycin in critically ill patients.
Llopis-Salvia P; Jiménez-Torres NV
J Clin Pharm Ther; 2006 Oct; 31(5):447-54. PubMed ID: 16958822
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetic Assessment of Vancomycin Loading Dose in Critically Ill Patients.
Álvarez O; Plaza-Plaza JC; Ramirez M; Peralta A; Amador CA; Amador R
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28607023
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of Vancomycin in Critically Ill Patients Undergoing Sustained Low-Efficiency Dialysis.
Rider TR; Silinskie KM; Hite MS; Bress J
Pharmacotherapy; 2020 Oct; 40(10):1036-1041. PubMed ID: 32866291
[TBL] [Abstract][Full Text] [Related]
40. Comparison of Race-Based and Non-Race-Based Equations for Kidney Function Estimation in Critically Ill Thai Patients for Vancomycin Dosing.
Sitaruno S; Santimaleeworagun W; Pattharachayakul S; DeBacker KC; Vattanavanit V; Binyala W; Pai MP
J Clin Pharmacol; 2022 Oct; 62(10):1215-1226. PubMed ID: 35543614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
